# Naltrexone Neuroimaging in Teens With Eating Disorders

> **NCT05509257** · EARLY_PHASE1 · RECRUITING · sponsor: **Children's Mercy Hospital Kansas City** · enrollment: 60 (estimated)

## Conditions studied

- Eating Disorders
- Binge Eating
- Purging (Eating Disorders)
- Bulimia Nervosa
- Anorexia Nervosa, Atypical

## Interventions

- **DRUG:** Naltrexone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05509257
- **Lead sponsor:** Children's Mercy Hospital Kansas City
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-17
- **Primary completion:** 2026-09
- **Final completion:** 2027-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-11-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05509257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05509257, "Naltrexone Neuroimaging in Teens With Eating Disorders". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05509257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*